Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Invesco DWA Healthcare Momentum ETF (PTH) belongs to the US Health Care segment. F/m Emerald Life Sciences Innovation ETF (LFSC) is part of the Life Sciences segment. Both ETFs have the same top 3 sector exposures: and Health Care. PTH is less expensive with a Total Expense Ratio (TER) of 0.72%, versus 0.79% for LFSC. PTH is down -0.94% year-to-date (YTD) with -$2M in YTD flows. LFSC performs worse with -3.7% YTD performance, and +$7M in YTD flows. Run a side-by-side ETF comparison of PTH and LFSC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PTH LFSC | +0.87%-2.09% | -2.99%-10.37% | -0.94%-3.70% | +31.67%+60.97% | +40.70%n/a | -4.17%n/a |
| Flows | PTH LFSC | -+$7M | -$2M+$8M | -$2M+$7M | -$15M+$18M | -$92M- | -$495M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PTH LFSC | +21.14%+22.01% | +24.53%+28.67% | +24.42%n/a | +25.61%n/a |
| Max drawdown | PTH LFSC | -7.58%-13.02% | -16.12%-19.03% | -29.24%n/a | -50.10%n/a |
| Max drawdown duration | PTH LFSC | 86d90d | 183d70d | 271dn/a | 1650dn/a |
PTH | LFSC | |
Last sale 3/11/2026 at 1:30 PM | $48.86 | $35.01 |
| Previous close 03/10/2026 | $49.20 | $35.21 |
| Consolidated volume 03/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
PTH | LFSC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
PTH | LFSC | |
|---|---|---|
| Last price | $48.86 | $35.01 |
| 1D performance | -0.70% | -0.57% |
| AuM | $122.13 M | $95.79 M |
| E/R | 0.72% | 0.79% |
PTH | LFSC | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Invesco | Emerald Group |
| Benchmark | Dorsey Wright Healthcare Technical Leaders Index | - |
| N° of holdings | 46 | 34 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 12, 2006 | October 31, 2024 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
